2008
DOI: 10.1016/j.surg.2008.06.008
|View full text |Cite
|
Sign up to set email alerts
|

The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
83
0
4

Year Published

2012
2012
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 118 publications
(89 citation statements)
references
References 21 publications
1
83
0
4
Order By: Relevance
“…Lymphadenectomy should precede enterectomy with possible ileoceccal valve preservation (10,18,28,35). R0 resection of both primary tumor and lymph node metastases is feasible in 80% of cases (10,18,19,36). Only in a minority of patients with bulky mesenteric masses is optimal debulking not feasible (36).…”
Section: Mesenteric Lymph Node Metastases and Desmoplastic Fibrosismentioning
confidence: 99%
See 1 more Smart Citation
“…Lymphadenectomy should precede enterectomy with possible ileoceccal valve preservation (10,18,28,35). R0 resection of both primary tumor and lymph node metastases is feasible in 80% of cases (10,18,19,36). Only in a minority of patients with bulky mesenteric masses is optimal debulking not feasible (36).…”
Section: Mesenteric Lymph Node Metastases and Desmoplastic Fibrosismentioning
confidence: 99%
“…R0 resection of both primary tumor and lymph node metastases is feasible in 80% of cases (10,18,19,36). Only in a minority of patients with bulky mesenteric masses is optimal debulking not feasible (36). However, surgical intervention may alleviate symptoms (36).…”
Section: Mesenteric Lymph Node Metastases and Desmoplastic Fibrosismentioning
confidence: 99%
“…However, many centres of excellence in nets have developed an aggressive surgical approach for these patients. Retrospective data have demonstrated improved survival in patients undergoing resection of the mesenteric disease compared with patients that did not (median survival: 11 years vs. 2.6 years) [37][38][39] . The suggestion is that resection of regional disease delayed onset of the obstruction and ischemia frequently seen in later stages of the disease.…”
Section: Summary Of Evidencementioning
confidence: 99%
“…The suggestion is that resection of regional disease delayed onset of the obstruction and ischemia frequently seen in later stages of the disease. Although these data are biased because of surgical selection, it does appear that aggressive surgical resection of regional disease may improve palliation in these patients, who are often experiencing ischemic symptoms 38,40 . Furthermore, some investigators have retrospectively shown an improved median pfs of 56 months compared with 25 months in patients whose primary tumour was resected in the face of advanced liver disease 41 .…”
Section: Summary Of Evidencementioning
confidence: 99%
See 1 more Smart Citation